Back to User profile » Dr Fabrizio Martora

Papers published by Dr Fabrizio Martora:


The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials

Potestio L, Martora F, Lauletta G, Vallone Y, Battista T, Megna M

Clinical, Cosmetic and Investigational Dermatology 2024, 17:829-842

Published Date: 10 April 2024

The Past, the Present and the Future of Teledermatology: A Narrative Review

Tommasino N, Megna M, Cacciapuoti S, Villani A, Martora F, Ruggiero A, Genco L, Potestio L

Clinical, Cosmetic and Investigational Dermatology 2024, 17:717-723

Published Date: 21 March 2024

Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report

Martora F, Battista T, Potestio L, Portarapillo A, Tommasino N, Megna M

Clinical, Cosmetic and Investigational Dermatology 2024, 17:483-487

Published Date: 29 February 2024

L-Lysine as an Alternative Treatment for Pityriasis Rosea (PR) [Response to Letter]

Potestio L, Martora F, Cacciapuoti S, Megna M, Villani A, Ruggiero A

Clinical, Cosmetic and Investigational Dermatology 2024, 17:463-464

Published Date: 24 February 2024

Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study

Martora F, Marasca C, Cacciapuoti S, Fariello F, Potestio L, Battista T, Scalvenzi M, Megna M

Clinical, Cosmetic and Investigational Dermatology 2024, 17:159-166

Published Date: 23 January 2024

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review

Potestio L, Martora F, Cacciapuoti S, Megna M, Villani A, Ruggiero A

Clinical, Cosmetic and Investigational Dermatology 2024, 17:51-57

Published Date: 8 January 2024

A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab

Megna M, Ruggiero A, Salsano A, Lauletta G, Portarapillo A, Torta G, Martora F, Potestio L

Clinical, Cosmetic and Investigational Dermatology 2023, 16:3503-3507

Published Date: 5 December 2023

Herpes Zoster and COVID-19 Vaccination: A Narrative Review

Potestio L, Megna M, Villani A, Cacciapuoti S, Scalvenzi M, Martora F

Clinical, Cosmetic and Investigational Dermatology 2023, 16:3323-3331

Published Date: 16 November 2023

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, Megna M

Clinical, Cosmetic and Investigational Dermatology 2023, 16:2525-2536

Published Date: 18 September 2023

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review

Potestio L, Camela E, Cacciapuoti S, Fornaro L, Ruggiero A, Martora F, Battista T, Megna M

Clinical, Cosmetic and Investigational Dermatology 2023, 16:2045-2059

Published Date: 4 August 2023

Nail Psoriasis: An Updated Review of Currently Available Systemic Treatments

Battista T, Scalvenzi M, Martora F, Potestio L, Megna M

Clinical, Cosmetic and Investigational Dermatology 2023, 16:1899-1932

Published Date: 24 July 2023

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?

Megna M, Camela E, Ruggiero A, Battista T, Martora F, Cacciapuoti S, Potestio L

Clinical, Cosmetic and Investigational Dermatology 2023, 16:1677-1690

Published Date: 28 June 2023

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature

Potestio L, Ruggiero A, Fabbrocini G, Martora F, Megna M

Psoriasis: Targets and Therapy 2023, 13:19-26

Published Date: 4 May 2023

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis

Potestio L, Martora F, Fabbrocini G, Battista T, Megna M

Psoriasis: Targets and Therapy 2023, 13:11-18

Published Date: 12 April 2023

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection

Potestio L, Piscitelli I, Fabbrocini G, Martora F, Ruggiero A, Megna M

Clinical, Cosmetic and Investigational Dermatology 2023, 16:369-373

Published Date: 5 February 2023

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience

Martora F, Megna M, Battista T, Potestio L, Annunziata MC, Marasca C, Villani A, Fabbrocini G

Clinical, Cosmetic and Investigational Dermatology 2023, 16:135-148

Published Date: 19 January 2023

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

Ruggiero A, Martora F, Fabbrocini G, Villani A, Marasca C, Megna M, Fornaro L, Comune R, Potestio L

Clinical, Cosmetic and Investigational Dermatology 2022, 15:2785-2793

Published Date: 19 December 2022

Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature

Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L

Clinical, Cosmetic and Investigational Dermatology 2022, 15:2369-2382

Published Date: 6 November 2022

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence

Ruggiero A, Picone V, Martora F, Fabbrocini G, Megna M

Clinical, Cosmetic and Investigational Dermatology 2022, 15:1649-1658

Published Date: 16 August 2022